Event-level impact of Promescent on quality of sexual experience in men with subjective premature ejaculation
| Autor: | Kristen P. Mark, I Kerner |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Ejaculation Sexual Behavior Urology media_common.quotation_subject Female sexual dysfunction 030232 urology & nephrology Orgasm 03 medical and health sciences 0302 clinical medicine Patient satisfaction Sexual medicine Premature ejaculation medicine Humans Prospective Studies Anesthetics Local Premature Ejaculation media_common Gynecology 030219 obstetrics & reproductive medicine business.industry Lidocaine Middle Aged medicine.disease Treatment Outcome Sexual dysfunction Erectile dysfunction Patient Satisfaction Physical therapy Original Article medicine.symptom business |
| Zdroj: | International Journal of Impotence Research |
| ISSN: | 1476-5489 0955-9930 |
| DOI: | 10.1038/ijir.2016.31 |
| Popis: | Promescent is a lidocaine-based ejaculation delaying spray that absorbs into the skin of the penis prior to sexual activity. This article aimed to evaluate the effect of Promescent on the experience of orgasm, ejaculatory latency time and quality of sexual experience (QSE). Additionally, we assessed ease of application of Promescent and the extent to which it enhanced or interrupted the sexual experience. The analytic sample consisted of 91 men with self-reported subjective premature ejaculation who were sent a sample of Promescent and completed a 14-day internet-based prospective daily electronic report. Average ejaculatory latency time was 11.16 min during product use events, compared with 6.81 min during product non-use events. Both members of the couple had an orgasm 65.6% of the time when they used the product, compared with 44.1% when they did not use the product. QSE was significantly improved on product use days (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink